VOLAC Glassware and FORTUNA® Liquid Handling launched into the USA

Poulten & Graf, with its specialty manufacturing facilities in England and Germany, is a supplier of medical and industrial glassware, as well as liquid handling products. Formed at the turn in 2000, the Poulten & Graf group is the result of the merging of two family businesses which, together, bring over 150 years of experience [...]

INTEGRA introduces 3-position stage for VIAFLO 96 / 384

INTEGRA has introduced a Three Position Stage for its VIAFLO 96 and VIAFLO 384 handheld benchtop pipettes. The new accessory expands available stage positions for microplates, reservoirs and tips on a VIAFLO 96 or VIAFLO 384 from 2 to 3 thereby enhancing workflow in a wide range of applications. Beneficially the Three Position Stage also [...]

Changes in Roche Board of Directors and enlarged Corporate Executive Committee

At its December meeting, the Board of Directors (BoD) of Roche Holding recommended first proposals for approval by the AGM, scheduled for 3 March 2015. All current members of the BoD will stand for re-election: Name, Board member since: Dr. Christoph Franz (as Chairman), 2011 André Hoffmann, 1996 Professor Dr. Pius Baschera,2007 Professor Sir John [...]

HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system

Huntsville, Ala. — — HudsonAlpha Institute for Biotechnology today announced it has purchased the HiSeq X Ten sequencing system manufactured by Illumina, Inc. (NASDQ: ILMN). The technology will enable HudsonAlpha to produce and analyze genomic data faster and at a lower cost. The purchase stems from the Institute’s commitment to research programs for genomics excellence [...]

Citrix Appoints Francis deSouza to Board of Directors

SANTA CLARA, CA. — Citrix Systems, Inc. (Nasdaq:CTXS) today announced the addition of Francis A. deSouza, technology industry veteran and president of Illumina, a leading biotechnology company, to its board of directors, effective immediately. deSouza began his career at IBM’s TJ Watson Research Center and went on to consult on technical and change management projects [...]

DANAHER COMPLETES ACQUISITION OF NOBEL BIOCARE

WASHINGTON -- Danaher Corporation (NYSE:DHR) announces that today it will settle the public tender offer for all the registered shares of Nobel Biocare Holding AG ("Nobel Biocare"). The additional acceptance period for the tender offer expired on December 4, 2014. Danaher now controls approximately 97% of the issued registered shares of Nobel Biocare. Sometime in [...]

Acquisition of Engineering Seismology Group

Spectris plc (“Spectris”) (LSE: SXS), the productivity-enhancing instrumentation and controls company, today announces that it has completed the acquisition of the privately-held Canadian group Engineering Seismology Group (“ESG”). The purchase consideration of C$64 million (approximately £36 million), on a debt and cash-free basis, will be met from existing cash and bank facilities and is subject [...]

Highly Efficient Neuro Transfection Reagent

AMSBIO announces DNA-In™ Neuro - a new generation transfection reagent developed specifically for maximum nucleic acid delivery into neurons, typically achieving a 2-fold or greater improvement in efficiency over currently available competing reagents. Neurons are among the most difficult cell types to transfect. DNA-In™ Neuro Transfection Reagent offers researchers a cost effective, robust and easy-to-use [...]

SP Industries Appoints New Chief Operating Officer

SP Industries (‘SP’) has announced that Brian Wright has joined the company as Chief Operating Officer effective October 27, 2014. In this role Mr. Wright will be responsible for all SP Industries factory operations, supply chain, logistics and facilities management. Prior to joining SP Industries Mr. Wright was Vice President of Franchise Pharmacy at Remedi [...]

Abbott’s Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe

ABBOTT PARK, Ill.-— Abbott today announced its innovative diagnostic platform, known as IRIDICA, is now available in Europe and other CE–Mark recognized countries. The new platform can identify more than 1,000 infection–causing pathogens in less than six hours, versus the current standard of care (culture-based testing), which can take days. By identifying the cause of [...]

Access IBO on Knowledge Center